Indication Half-life (T1/2), Metabolism Notable Side Effects Initial Dosing
Neurotransmitter(s) (CYP 450 enzyme) (link to NT or affected Considerations
Affected brain circuit) Specific lifespan
Target Symptoms considerations (age,
pregnancy,
breastfeeding)
Buprenorphine • Indications: • Metabolized by • Notable side • Initial dosing:
(Subutex) Induction of CYP450 3A4. effects: Day 1: 8 mg
treatment for • Elimination half-life of Headache, Day 2: 12-16
opioid dependence sublingual constipation, mg Days 3-7:
(Bunavail only), buprenorphine is 24-42 nausea, oral Increase in
maintenance hours. hypoesthesia, increments of 4
treatment of • Elimination half-life glossodynia, mg, maximum
opioid dependence naloxone is 2-12 hours. orthostatic 32 mg.
(sublingual), • Implant: Tmax is 12 hypotension, • Consideration
maintenance hours; time to steady implant specific: s: Use with
state is 4 weeks.
treatment of insertion site caution in the
opioid dependence pain, pruritus, elderly and
in patients who erythema. those with
have achieved and • Life- cardiac
sustained threatening side impairment. It
prolonged clinical effects: may be
stability on low- Respiratory preferable to
to-moderate doses depression, methadone in
(no more than hepatoxicity. pregnant
8mg) of a • How drug women.
transmucosal causes side Neonatal
buprenorphine- effects: Binding withdrawal
containing product at mu opioid may occur. The
(implant), receptors. drug is found in
moderate to serve breast milk and
opioid use is
disorder in recommended
NR 546 week 6 medication table
, patients who have for DC drug or
initiated treatment bottle feed.
with a Safety and
transmucosal efficacy have
buprenorphine- not been
containing established for
product, followed children and
by dose adolescents.
adjustment for a
minimum of 7
days (injection).
• Neurotransmitter
s affected: Mu
opioid receptor
partial agonist.
Binds with a
strong affinity to
the mu opioid
receptor,
preventing
exogenous opioids
from binding there
and thus
preventing the
pleasurable effects
of opioid
consumption.
• Target
symptoms: opioid
dependence.
Buprenorphine/ • Indications: • Half-life: Suboxone: • Notable side • Initial dosing:
Naloxone (Suboxone, Induction of 24-42 hours effects: Bunavail: Day
Zubsolv, Bunavail) treatment for • Naloxone: 2-12 hours Headache, 1: induction
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Mboffin. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.99. You're not tied to anything after your purchase.
